These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 30629980)

  • 61. The neurobiology of impulse control disorders in Parkinson's disease: from neurotransmitters to neural networks.
    Vriend C
    Cell Tissue Res; 2018 Jul; 373(1):327-336. PubMed ID: 29383446
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Nicotinic receptors and cognition in Parkinson's Disease: the importance of neuronal synchrony.
    Forgacs PB; Bodis-Wollner I
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1317-31. PubMed ID: 15480841
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Oscillatory subthalamic nucleus activity is modulated by dopamine during emotional processing in Parkinson's disease.
    Huebl J; Spitzer B; Brücke C; Schönecker T; Kupsch A; Alesch F; Schneider GH; Kühn AA
    Cortex; 2014 Nov; 60():69-81. PubMed ID: 24713195
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Characterization of a presymptomatic stage in a Drosophila Parkinson's disease model: Unveiling dopaminergic compensatory mechanisms.
    Molina-Mateo D; Fuenzalida-Uribe N; Hidalgo S; Molina-Fernández C; Abarca J; Zárate RV; Escandón M; Figueroa R; Tevy MF; Campusano JM
    Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2882-2890. PubMed ID: 28716706
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Depression in Parkinson's disease.
    Murray JB
    J Psychol; 1996 Nov; 130(6):659-67. PubMed ID: 8914304
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Dopaminergic dysregulation, artistic expressiveness, and Parkinson's disease.
    López-Pousa S; Lombardía-Fernández C; Olmo JG; Monserrat-Vila S; Vilalta-Franch J; Calvó-Perxas L
    Case Rep Neurol; 2012 Sep; 4(3):159-66. PubMed ID: 23185168
    [TBL] [Abstract][Full Text] [Related]  

  • 67. We need to move more: Neurobiological hypotheses of physical exercise as a treatment for Parkinson's disease.
    Monteiro-Junior RS; Cevada T; Oliveira BR; Lattari E; Portugal EM; Carvalho A; Deslandes AC
    Med Hypotheses; 2015 Nov; 85(5):537-41. PubMed ID: 26209418
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Does education modify motor compensation in Parkinson's disease?
    Sunwoo MK; Hong JY; Lee JJ; Lee PH; Sohn YH
    J Neurol Sci; 2016 Mar; 362():118-20. PubMed ID: 26944130
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Attention and visual dysfunction in Parkinson's disease.
    Botha H; Carr J
    Parkinsonism Relat Disord; 2012 Jul; 18(6):742-7. PubMed ID: 22503538
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Parkinson's disease: Mechanisms, translational models and management strategies.
    Raza C; Anjum R; Shakeel NUA
    Life Sci; 2019 Jun; 226():77-90. PubMed ID: 30980848
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Toward Model Building for Visual Aesthetic Perception.
    Liu J; Lughofer E; Zeng X
    Comput Intell Neurosci; 2017; 2017():1292801. PubMed ID: 29270194
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours.
    Lhommée E; Klinger H; Thobois S; Schmitt E; Ardouin C; Bichon A; Kistner A; Fraix V; Xie J; Aya Kombo M; Chabardès S; Seigneuret E; Benabid AL; Mertens P; Polo G; Carnicella S; Quesada JL; Bosson JL; Broussolle E; Pollak P; Krack P
    Brain; 2012 May; 135(Pt 5):1463-77. PubMed ID: 22508959
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Qualitative Bioinformatics: Towards a Public Understanding of Neurodegenerative Disease Research through BioArt, Data-Art, Hands-on BioMedia Workshops, Immersive Environments, and Artists in Labs.
    Zaretsky A
    Adv Exp Med Biol; 2023; 1425():663-664. PubMed ID: 37581839
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mimicking Parkinson's Disease in a Dish: Merits and Pitfalls of the Most Commonly used Dopaminergic In Vitro Models.
    Lopes FM; Bristot IJ; da Motta LL; Parsons RB; Klamt F
    Neuromolecular Med; 2017 Sep; 19(2-3):241-255. PubMed ID: 28721669
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Visual dysfunction in Parkinson's disease.
    Rodnitzky RL
    Clin Neurosci; 1998; 5(2):102-6. PubMed ID: 10785835
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Motor deficits and beta oscillations are dissociable in an alpha-synuclein model of Parkinson's disease.
    Brys I; Nunes J; Fuentes R
    Eur J Neurosci; 2017 Aug; 46(3):1906-1917. PubMed ID: 28370471
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Creativity, art and brain: Comment on "Can we really 'read' art to see the changing brain? A review and empirical assessment of clinical case reports and published artworks for systematic evidence of quality and style changes linked to damage or neurodegenerative disease" by Matthew Pelowski et al.
    Bogousslavsky J
    Phys Life Rev; 2023 Mar; 44():116-118. PubMed ID: 36634557
    [No Abstract]   [Full Text] [Related]  

  • 78. Artistic creativity and dementia.
    Miller ZA; Miller BL
    Prog Brain Res; 2013; 204():99-112. PubMed ID: 24041320
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Neuroaesthetical Changes in Sculpture: The Case of Yannoulis Halepas (1851-1938).
    Stefanou MI; Ziemann U
    Eur Neurol; 2019; 82(4-6):116-123. PubMed ID: 31918427
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The Cerebellum and Beauty: The Impact of the Cerebellum in Art Experience and Creativity.
    Adamaszek M; Cattaneo Z; Ciricugno A; Chatterjee A
    Adv Exp Med Biol; 2022; 1378():213-233. PubMed ID: 35902474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.